CHARLES SCHWAB INVESTMENT MANAGEMENT INC - NGM BIOPHARMACEUTICALS INC ownership

NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of NGM BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$294,318
-58.2%
275,064
+1.2%
0.00%
Q2 2023$703,672
-47.0%
271,688
-16.4%
0.00%
Q1 2023$1,326,506
-19.4%
325,124
-0.9%
0.00%
-100.0%
Q4 2022$1,646,429
-60.0%
327,974
+4.3%
0.00%0.0%
Q3 2022$4,115,000
+3.0%
314,559
+0.9%
0.00%0.0%
Q2 2022$3,996,000
-12.5%
311,675
+4.0%
0.00%0.0%
Q1 2022$4,569,000
-8.0%
299,547
+6.8%
0.00%0.0%
Q4 2021$4,968,000
-14.1%
280,468
+1.9%
0.00%
-50.0%
Q3 2021$5,786,000
+61.1%
275,246
+51.1%
0.00%
+100.0%
Q2 2021$3,592,000
-24.6%
182,110
+11.1%
0.00%
-50.0%
Q1 2021$4,767,000
+19.7%
163,973
+24.7%
0.00%0.0%
Q4 2020$3,984,000
+93.1%
131,499
+1.4%
0.00%
+100.0%
Q3 2020$2,063,000
+27.3%
129,660
+58.0%
0.00%0.0%
Q2 2020$1,620,000
+62.7%
82,061
+1.7%
0.00%0.0%
Q1 2020$996,000
-31.9%
80,707
+2.1%
0.00%0.0%
Q4 2019$1,462,000
+160.6%
79,052
+95.4%
0.00%
Q3 2019$561,000
-0.5%
40,461
+5.1%
0.00%
Q2 2019$564,00038,4870.00%
Other shareholders
NGM BIOPHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Greenspring Associates, LLC 1,573,357$47,665,00061.89%
RHO CAPITAL PARTNERS INC 3,766,666$114,111,00060.06%
Column Group LLC 15,396,116$466,502,00042.31%
Ponoi II Management, LLC 1,298,908$39,357,00028.68%
Ponoi Management, LLC 1,298,908$39,357,00022.52%
Euclidean Capital LLC 2,083,602$63,133,00013.36%
Aquilo Capital Management, LLC 1,005,534$30,463,0006.33%
Octagon Capital Advisors LP 75,227$2,279,0000.79%
Jasper Ridge Partners, L.P. 308,750$9,354,0000.41%
Point72 Asset Management, L.P. 1,761,157$53,354,0000.26%
View complete list of NGM BIOPHARMACEUTICALS INC shareholders